New Jersey 2026-2027 Regular Session

New Jersey Senate Bill S2621

Introduced
1/13/26  

Caption

Establishes "Equitable Drug Pricing and Patient Access Act."

Impact

The bill stipulates that reimbursement rates for prescription drug services under the Medicaid program will be set at no less than the national average drug acquisition cost plus a fixed dispensing fee. This provision aims to improve financial transparency and fairness in Medicaid reimbursement, potentially leading to savings for the state. Additionally, by requiring the inclusion of pharmacy choice in Medicaid contracts, the legislation seeks to empower enrollees and enhance their access to prescriptions, which is particularly critical in a landscape where rising drug prices have significantly impacted consumers.

Summary

Senate Bill S2621, known as the 'Equitable Drug Pricing and Patient Access Act,' aims to address the growing concerns regarding Medicaid prescription drug pricing and the availability of pharmacy services. It mandates that Medicaid managed care contracts include pharmacy choice as a required benefit, allowing enrollees the flexibility to select any qualified pharmacy that accepts the state Medicaid program's terms. This change is expected to enhance competition among pharmacies and ensure that patients have a wide selection of providers available to them for prescription services.

Contention

While the intent of S2621 is to foster greater accessibility and affordability within the Medicaid system, there may be concerns from certain stakeholders regarding the financial implications for pharmacies and the administrative burden on Medicaid managed care organizations. Discussions in the legislative context may raise questions about how these changes will affect the existing framework for Medicaid managed care and whether they will lead to unintended consequences for both enrollees and providers. Ensuring the intended benefits without disrupting the stability of pharmacy services and Medicaid operations will likely be a balancing act for lawmakers and regulators moving forward.

Companion Bills

NJ S3538

Carry Over Establishes "Equitable Drug Pricing and Patient Access Act."

NJ A5531

Carry Over Establishes "Equitable Drug Pricing and Patient Access Act."

NJ A3512

Same As Establishes "Equitable Drug Pricing and Patient Access Act."

Similar Bills

NJ A3512

Establishes "Equitable Drug Pricing and Patient Access Act."

HI SB2208

Relating To Pharmacy Benefit Managers.

NV SB389

Revises provisions relating to the administration of pharmacy benefits under Medicaid and certain other health plans. (BDR 38-240)

FL H0657

Medicaid Pharmacy Discounted Drug Prices

NV SB149

Revises provisions governing the administration of pharmacy benefits under Medicaid. (BDR 38-224)

FL H0697

Drug Prices and Coverage

SC S0342

Pharmacy services

AR HB1354

To Regulate Pharmacy Benefits Managers; To Amend The Law Concerning The State And Public School Life And Health Insurance Program; And To Amend The Law Concerning Certain Health Benefit Plans.